Interferon alpha-2b
Clinical Outcome of Topical Interferon Alpha 2b Cream in Phase II Trial for LSIL/CIN 1 Patients
6
Response Surface Optimization of the Expression Conditions for Synthetic Human Interferon alpha-2b Gene in Escherichia coli
10
Effects of Interferon Alpha 2b on VEGFR 2, VEGFA, MAPK 1 and ERK 1 Gene Expression in Corneal Neovascularization Models
9
Design of an efficient medium for heterologous protein production in Yarrowia lipolytica: case of human interferon alpha 2b
13
Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review
10
Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin
8
<em>TERT </em>copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma
8
Development of a cultivation process for the enhancement of human interferon alpha 2b production in the oleaginous yeast, Yarrowia lipolytica
11
Improved Sustained Virological Response Following Treatment with Pegylated Interferon Alpha 2b Compared with Alpha 2a, Both with Ribavirin, for Chronic Hepatitis C Infection with Genotypes 2 and 3
7
Enabling low cost biopharmaceuticals: high level interferon alpha-2b production in Trichoderma reesei
15
Overwhelming Postsplenectomy Infection for Splenectomized HCV Patients
5
Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis
8
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
9
Pegylated interferon alpha 2a and 2b in combination with ribavirin in the treatment of chronic hepatitis C : a systematic review and economic evaluation
148
Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer
10
Differential expression of interferon induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
9
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
10
Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil
9
Melanoma treatment in review
15
Recognition of herpesviruses by the innate immune system
42